Published on:

Xarelto® Litigation Update – Johnson & Johnson and Bayer Settle for $775 Million

Reyes Browne Reilley - Xarelto® Litigation Update - Johnson & Johnson and Bayer Settle for $775 Million smallMARCH 25, 2019 – Bayer and Johnson & Johnson have agreed to settle roughly 25,000 lawsuits that resulted from their blood thinner medicine, Xarelto®. Both companies will pay a sum of $775 million, split evenly between the two companies.

Both companies deny liability, and still stand behind their product albeit thousands of patients suffering from irreversible internal bleeding. Instead, they have decided to settle because of the extensive time and resources devoted to litigation.

The most serious potential injury caused by Xarelto® is internal bleeding. Currently, there is no known potential cure to reverse the type of blood loss caused by Xarelto®, other than possibly emergency dialysis.

Serious Side Effects Include:

  • Stroke
  • Intracranial hemorrhage
  • Epidural hemorrhage
  • Gastrointestinal hemorrhage
  • Retinal hemorrhage
  • Adrenal hemorrhage
  • Death

If you or a loved one suffered a harmful side effect such as a stroke, blood clot, or internal bleeding while taking Xarelto®, you may have a valuable legal claim.

Your next move should be to contact us for a free consultation to determine if you have a claim for compensation. Your consultation will be handled with the utmost compassion and confidentiality. If it’s determined that you should move forward with a claim, we will work with you every step of the way to see you through this process.

Call us now at (214) 526-7900 or email us at help@reyeslaw.com for a free and confidential case review with one of our dangerous drug attorneys.

Contact Information